AHR-10282,
bromfenac,
bromfenac sodium,
Duract,
ISV-303,
sodium bromfenac,
Xibrom,
Bromfenac Sodium Sesquihydrate,
120638-55-3,
Xibrom,
Duract,
Bromfenac sodium [USAN],
UNII-8ECV571Y37,
AHR 10282B,
CHEBI:59176,
sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate,
8ECV571Y37,
BromSite,
Bromfenac sodium (USAN),
Sodium 2-(2-amino-3-(4-bromobenzoyl)phenyl)acetate hydrate(2:2:3),
Bromfenac monosodium salt sesquihydrate,
DSSTox_CID_24206,
DSSTox_RID_80119,
DSSTox_GSID_44206,
Bromfenac sodium hydrate,
Sodium (2-amino-3-(p-bromobenzoyl)phenyl)acetate sesquihydrate,
Benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-, monosodium salt, hydrate (2:3),
Benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-, monosodium salt, sesquihydrate,
Bromfenac ophthalmic,
AHR-10282B,
bromfenac sodium salt sesquihydrate,
CAS-120638-55-3,
NCGC00164552-01,
Bromfenac ophthalmic solution,
sodium [2-amino-3-(p-bromobenzoyl)phenyl]acetate sesquihydrate,
Prolensa (TN),
Bromday (TN),
Xibrom (TN),
Yellox (TN),
Bromfenac(sodiumhydrate),
Bromfenac sodium hydrate (JAN),
CHEMBL3181947,
DTXSID8044206,
KS-00001FCL,
2C15H11BrNO3.2Na.H2O,
Tox21_112181,
AKOS016008745,
Tox21_112181_1,
NCGC00263519-01,
BC215663,
LS-172462,
D03163,
sodium [2-amino-3-(4-bromobenzoyl)phenyl]acetate sesquihydrate,
Sodium 2-(2-amino-3-(4-bromobenzoyl)phenyl)acetate trihydrate,
disodium;2-[2-amino-3-(4-bromobenzoyl)phenyl]acetate;trihydrate,
sodium [2-amino-3-(4-bromobenzoyl)phenyl]acetate--water (2/3),
2-amino-3-(4-bromobenzoyl)benzene-acetic acid sodium salt sesquihydrate,
Bromfenac,
BROMFENAC SODIUM,
C15H12BrNO3.3/2H2O.Na,
CID11954316,
C15-H12-Br-N-O3.3/2H2-O.Na,
Sodium (2-amino-3-(4-bromobenzoyl)phenyl)acetate,
2-AMINO-3-(4-BROMOBENZOYL)BENZENEACETIC ACID SODIUM SALT,